DeepMed Research

HistoSonics, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Holding

Established: 2009-01-01

Employees: 51

Market Cap: -

Website: http://www.histosonics.com

Clinical Trials

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Recruiting

Conditions: Liver Neoplasms
Benign Liver Tumor
Tumor Liver
Primary Liver Cancer
Secondary Liver Cancer

Interventions: Device: HistoSonics Edison System

First Posted Date: 2024-07-03

Last Posted Date: 2025-03-12

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 5000

Registration Number: NCT06486454

Locations: 🇺🇸
Mission Hospital, Mission Viejo, California, United States
🇺🇸
AdventHealth Altamonte Springs, Altamonte Springs, Florida, United States
🇺🇸
AdventHealth Celebration, Celebration, Florida, United States

and more 5 locations

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Not Applicable

Recruiting

Conditions: Pancreatic Cancer
Tumor of Pancreas
Adenocarcinoma of the Pancreas
Pancreas Cancer

Interventions: Device: HistoSonics Edison™ System for the treatment of pancreatic adenocarcinoma using histotripsy

First Posted Date: 2024-02-28

Last Posted Date: 2025-01-09

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 50

Registration Number: NCT06282809

Locations: 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Not Applicable

Recruiting

Conditions: Renal Cancer
Tumor, Solid
Tumor, Benign
Tumor
Kidney Cancer

Interventions: Device: HistoSonics Edison System

First Posted Date: 2023-04-19

Last Posted Date: 2025-01-17

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 68

Registration Number: NCT05820087

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸
Providence Mission Hosptial, Mission Viejo, California, United States

and more 12 locations

The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy

Not Applicable

Active, not recruiting

Conditions: Tumor, Benign
Tumor, Solid
Kidney Neoplasms
Renal Cancer
Kidney Cancer
Tumor

Interventions: Device: HistoSonics Investigational System

First Posted Date: 2022-06-27

Last Posted Date: 2025-05-02

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 20

Registration Number: NCT05432232

Locations: 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

Not Applicable

Active, not recruiting

Conditions: Hepatocellular Carcinoma
Liver Metastases
Liver Neoplasms

Interventions: Device: HistoSonics System

First Posted Date: 2020-10-05

Last Posted Date: 2025-05-06

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 24

Registration Number: NCT04573881

Locations: 🇩🇪
Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany
🇩🇪
Universitätsklinikum Magdeburg Klinik für Radiologie und Nuklearmedizin, Magdeburg, Germany
🇮🇹
Istituto Clinico Humanitas - Humanitas Mirasole S.P.A., Milano, Italy

and more 3 locations

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy

Not Applicable

Active, not recruiting

Conditions: Hepatocellular Carcinoma
Liver Metastases
Liver Neoplasms

Interventions: Device: HistoSonics System

First Posted Date: 2020-10-01

Last Posted Date: 2025-05-06

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 47

Registration Number: NCT04572633

Locations: 🇺🇸
Tampa General Hospital, Tampa, Florida, United States
🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States
🇺🇸
University Hospital - UW Health, Madison, Wisconsin, United States

and more 4 locations

Study to Evaluate VORTX Rx (Theresa)

Not Applicable

Completed

Conditions: Carcinoma, Hepatocellular
Liver Metastases

Interventions: Device: VORTX Rx treatment

First Posted Date: 2018-11-14

Last Posted Date: 2021-04-20

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 8

Registration Number: NCT03741088

Locations: 🇪🇸
Hospital Universitario Vall d´Hebrón, Barcelona, Spain
🇪🇸
Hospital universitario Mutua Terrassa, Terrassa, Barcelona, Spain
🇪🇸
Clinica Diagonal, Esplugues De Llobregat, Barcelona, Spain

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

Not Applicable

Terminated

Conditions: Benign Prostatic Hyperplasia (BPH)

Interventions: Device: Vortx Rx - Histotripsy BPH Device

First Posted Date: 2013-07-11

Last Posted Date: 2023-11-07

Lead Sponsor: HistoSonics, Inc.

Target Recruit Count: 28

Registration Number: NCT01896973

Locations: 🇺🇸
Univerisity of Michigan, Ann Arbor, Michigan, United States
🇺🇸
ProMedica Parkway Surgery Center, Toledo, Ohio, United States

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Not Applicable

Withdrawn

Conditions: Benign Prostatic Hyperplasia (BPH)

Interventions: Device: Vortx Rx - Histotripsy BPH Device

First Posted Date: 2013-01-25

Last Posted Date: 2015-08-19

Lead Sponsor: HistoSonics, Inc.

Registration Number: NCT01775488

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy